Presence of interleukin-17C in the tissue around aseptic loosened implants

Int Orthop. 2013 May;37(5):953-9. doi: 10.1007/s00264-013-1812-x. Epub 2013 Mar 10.

Abstract

Purpose: The most common long-term complication of joint arthroplasty is aseptic loosening. The proinflammatory cytokines secreted by macrophages are involved in aseptic loosening. Recently, a novel proinflammatory cytokine IL-17C was reported to participate in inflammatory diseases by synergising with proinflammatory cytokines. However, the relationship between IL-17C and the aseptic loosening is unclear.

Methods: The tissues around aseptic loosened implants were collected during revision surgery and handled by formalin fixation and embedded in paraffin. The presence of IL-17C in the tissues around the aseptic loosened implants was investigated in 12 aseptic loosening patients using immunofluorescence.

Results: The presence of IL-17C protein in the tissues around aseptic loosened implants was detected by immunofluorescence. There are no statistical differences between optical density of IL-17C in aseptic loosening samples and in rheumatoid arthritis samples (positive control).

Conclusions: These results suggest the presence of IL-17C in aseptic loosening. Interleukin-17C was related to the inflammation of aseptic loosening, possibly by contributing to the inflammation and osteolysis in the tissues surrounding aseptic loosened implants.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Arthroplasty, Replacement, Hip / adverse effects*
  • Asepsis*
  • Female
  • Humans
  • Inflammation / metabolism
  • Inflammation / pathology
  • Interleukin-17 / metabolism*
  • Joint Prosthesis*
  • Male
  • Middle Aged
  • Osteolysis / metabolism
  • Osteolysis / pathology
  • Preoperative Period
  • Prosthesis Failure*

Substances

  • Interleukin-17